Skip to main content
SpringerLink
Log in

Leukotriene receptor blockade in experimental heart failure

  • Published:
Research in Experimental Medicine

Abstract

The pathophysiological role of endogenous leukotrienes in cardiovascular control and the regulation of renal function in congestive heart failure is not known. Therefore, in six conscious dogs with or without heart failure induced by right ventricular pacing (270/min, 10 days) we studied the effects of the leukotriene receptor antagonist FPL55712 on hemodynamics, plasma hormones and renal function. In healthy dogs, FPL55712 (1 mg kg−1 + 0.01 mg kg−1 min−1 i. v.) had little effect on hemodynamics, only reducing heart rate by 11% and insignificantly increasing systemic vascular resistance. Plasma levels of norepinephrine (−57%), renin (−30%) and aldosterone (−24%) were significantly decreased. Renal function parameters were not changed. In dogs with heart failure, FPL55712 significantly increased systemic vascular resistance (+16%) and decreased cardiac output (−15%). Plasma hormone levels were not changed, but renal plasma flow was decreased (−13%) and glomerular filtration rate (+12%), renal vascular resistance (+13%) and filtration fraction (+23%) were increased. It is concluded that there is no evidence for a contribution of endogenous leukotrienes to the systemic vaso-constriction in experimental heart failure. Whether the increase in systemic and renal vascular resistance induced by the leukotriene antagonist in dogs with heart failure reflects a role for endogenous leukotrienes with vasodilator action is still unclear and deserves further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anton AH, Sayre DF (1962) A study of the factor affecting the aluminium-trihydroxy-indole for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360–375

    CAS  PubMed  Google Scholar 

  2. Armstrong PW, Terrance PS, Ford SE, DeBold AJ (1986) Rapid right ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 74: 1075–1084

    Article  CAS  PubMed  Google Scholar 

  3. Augstein J, Farmer JB, Lee TB, Sheard P, Tattersall ML (1973) Selective inhibitor of slow reacting substance of anaphylaxis. Nature 245: 215–217

    Article  CAS  Google Scholar 

  4. Badr KF, Baylis C, Pfeffer JM, Pfeffer MA, Soberman RJ, Lewis RA, Austen F, Corey EJ, Brenner BM (1984) Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat. Circ Res 54: 492–499

    Article  CAS  PubMed  Google Scholar 

  5. Bisgaard H, Kristenson J, Sondergaard J (1982) The effect of leukotriene C4 and D4 on cutaneous blood flow in humans. Prostaglandins 23: 797–801

    Article  CAS  PubMed  Google Scholar 

  6. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinsons AW, Tagari P (1992) Increased urinary leukotriene excretion in patients with cardiac ischemia; in vivo evidence for 5-lipoxygenase activation. Circulation 85: 230–236

    Article  CAS  PubMed  Google Scholar 

  7. Chasin M, Scott C (1978) Inhibition of cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist. Biochem Pharmacol 27: 2065–2067

    Article  CAS  PubMed  Google Scholar 

  8. Dembinska-Kiec A, Simmet T, Peskar BA (1984) Formation of leukotrine C4-like material by rat brain tissue. Eur J Pharmacol 99: 57–62

    Article  CAS  PubMed  Google Scholar 

  9. Dumitriu D, Prie S, Bernier SG, Guillemette G, Sirois P (1997) Mechanism of action of leukotriene D4 on guinea pig tracheal smooth muscle cells:role of Ca2+ influx and intracellular Ca2+ release. J Pharmacol Exp Ther 280: 1357–1365

    CAS  PubMed  Google Scholar 

  10. Dzau VJ, Packer M, Lilly L, Swartz SL, Hollenberg NK, Williams GH (1984) Prostaglandins in severe congestive heart failure. N Engl J Med 310: 347–352

    Article  CAS  PubMed  Google Scholar 

  11. Eimerl J, Siren AL, Feuerstein G (1986) Systemic and regional hemodynamic effects of leukotrienes D4 and E4 in the conscious rat. Am J Physiol 251: H700–H709

    CAS  PubMed  Google Scholar 

  12. Elsner D, Kromer EP, Riegger GAJ (1990) Hemodynamic, hormonal and renal effects of the prostacyclin analogue iloprost in conscious dogs with and without heart failure. J Cardiovasc Pharmacol 16: 601–608

    Article  CAS  PubMed  Google Scholar 

  13. Fauler J, Frölich JC (1989) Cardiovascular effects of leukotrienes. Cardiovasc Drugs Thre 3: 499–505

    Article  CAS  Google Scholar 

  14. Feigen LP (1983) Differential effects of leukotrienes C4, D4, and E4 in the canine renal and mesenteric vascular beds. J Pharmacol Exp Ther 225: 682–687

    CAS  PubMed  Google Scholar 

  15. Feuerstein G, Hallenbeck JM (1987) Leukotrienes in health and disease. FASEB J 1: 186–192

    CAS  PubMed  Google Scholar 

  16. Fiedler VB, Mardin M, Abram TS (1987) Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. Basic Res Cardiol 82: 197–208

    Article  CAS  PubMed  Google Scholar 

  17. Filep J, Földes-Filep E, Frölich JC (1987) Vascular responses to leukotrienes B4, C4 and D4 following FPL55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat. Br J Pharmacol 90: 431–439

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Fleisch JH, Rinkema LE, Marshall WS (1984) Pharmacological receptors for the leukotrienes. Biochem Pharmacol 33: 3919–3922

    Article  CAS  PubMed  Google Scholar 

  19. Gulbins E, Parekh N, Rauterberg EW, Schlottmann K, Steinhausen M (1991) Cysteinyl leukotriene actions on the microcirculation of the normal and split hydronephrotic rat kidney. Eur J Clin Invest 21: 184–196

    Article  CAS  PubMed  Google Scholar 

  20. Hirsch AT, Dzau VJ, Creager MA (1987) Baroreceptor function in congestive heart failure: effect of neurohumoral activation and regional vascular resistance. Circulation 75 (Suppl IV): 36–48

    Google Scholar 

  21. Holroyde MC, Altounyan PEC, Cole M, Dixon M, Elliott EV (1981) Leukotrienes C and D induce bronchoconstriction in man. Agents Actions 11: 573–574

    Article  CAS  PubMed  Google Scholar 

  22. Marone G, Giordano A, Cirillo R, Triggiani M, Vigorito C (1988) Cardiovascular and metabolic effects of peptide leukotrienes in man. In: Levi R, Krell RD (eds) Biology of the leukotrienes. Ann NY Acad Sci 524: 321–333

    Google Scholar 

  23. Murphy RC, Hammarström S, Samuelsson B (1979) Leukotriene C: a slow reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76:4275–4279

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Ochsner M (1996) The action of the peptidoleukotriene LTD4 on intracellular calcium in rat mesangial cells. Experientia 52: 856–864

    Article  CAS  PubMed  Google Scholar 

  25. Packer H, Lee WH, Kessler PD (1986) Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation 74: 766–774

    Article  CAS  PubMed  Google Scholar 

  26. Packer M (1988) Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77: 721–730

    Article  CAS  PubMed  Google Scholar 

  27. Peck MJ, Piper PJ, Williams TJ (1981) The effect of leukotrienes C4 and D4 on the microvasculature of guinea pig skin. Prostaglandins 21: 315–321

    Article  CAS  PubMed  Google Scholar 

  28. Prasad K, Kalra J (1988) Oxygen free radicals and heart failure. Angiology 39: 417–420

    Article  CAS  PubMed  Google Scholar 

  29. Riegger GAJ, Liebau G (1982) The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci 62: 465–469

    CAS  PubMed  Google Scholar 

  30. Riegger GAJ, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K (1988) Atrial natriuretic peptide in congestive heart failure in the dog:plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells and hemodynamic, hormonal and renal effects. Circulation 77: 398–406

    Article  CAS  PubMed  Google Scholar 

  31. Riegger GAJ, Elsner D, Kromer EP (1989) Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs. Am J Physiol 256: H1079–H1086

    CAS  PubMed  Google Scholar 

  32. Schalling M, Neil A, Terenius L, Lindgren JA, Miamoto T, Hökfelt T, Samuelsson B (1984) Leukotriene C4 binding sites in the rat central nervous system. Eur J Pharmacol 99: 57–62

    Article  Google Scholar 

  33. Secrest RJ, Olsen EJ, Chapnick BM (1985) Leukotriene D4 relaxes canine renal and superior mesenteric arteries. Circ Res 57: 323–329

    Article  PubMed  Google Scholar 

  34. Snyder DW, Bernstein PR (1987) Pharmacologic profile of chemically stable analogs of peptide leukotrienes. Eur J Pharmacol 138: 397–405

    Article  CAS  PubMed  Google Scholar 

  35. Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47: 1–9

    Article  CAS  PubMed  Google Scholar 

  36. Welton AF, Hope WC, Tobias LD, Hamilton JG (1981) Inhibition of antigen-induced histamine release and thromboxane synthase by FPL55712, a specific SRS-A antagonist. Biochem Pharmacol 30: 1378–1382

    Article  CAS  PubMed  Google Scholar 

  37. Zukowska-Grojec Z, Bayorh MA, Kopin IJ, Feuerstein G (1982) Leukotriene D4:cardiovascular and sympathetic effects in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. J Pharmacol Exp Ther 223: 183–187

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum, D-93042, Regensburg, Germany

    Michael Pfeifer, Frank Muders, Andreas Luchner, Friedrich Blumberg, Günter A. J. Riegger & Dietmar Elsner

Authors
  1. Michael Pfeifer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank Muders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas Luchner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Friedrich Blumberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Günter A. J. Riegger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dietmar Elsner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfeifer, M., Muders, F., Luchner, A. et al. Leukotriene receptor blockade in experimental heart failure. Res. Exp. Med. 197, 177–187 (1997). https://doi.org/10.1007/s004330050067

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004330050067

Key words

Search

Navigation